Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia | Zendy

Naif Khalaf Alharbi | Zendy; Suliman Alghnam | Zendy; Abdullah Algaissi | Zendy; Hind Albalawi | Zendy; Mohammed W. Alenazi | Zendy; Areeb M. Albargawi | Zendy; Abdullah G. Alharbi | Zendy; Abdulaziz Alhazmi | Zendy; Ali Al Qarni | Zendy; Ali Alfarhan | Zendy; Hosam M. Zowawi | Zendy; Hind Alhatmi | Zendy; Jahad Alghamdi | Zendy; Fayhan Alroqi | Zendy; Khalid Batarfi | Zendy; Yaseen M. Arabi | Zendy; Anwar M. Hashem | Zendy; Mohammed Bosaeed | Zendy; Omar Aldibasi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia

Author(s) -

Naif Khalaf Alharbi,

Suliman Alghnam,

Abdullah Algaissi,

Hind Albalawi,

Mohammed W. Alenazi,

Areeb M. Albargawi,

Abdullah G. Alharbi,

Abdulaziz Alhazmi,

Ali Al Qarni,

Ali Alfarhan,

Hosam M. Zowawi,

Hind Alhatmi,

Jahad Alghamdi,

Fayhan Alroqi,

Khalid Batarfi,

Yaseen M. Arabi,

Anwar M. Hashem,

Mohammed Bosaeed,

Omar Aldibasi

Publication year - 2021

Publication title -

journal of infection and public health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.983

H-Index - 35

eISSN - 1876-035X

pISSN - 1876-0341

DOI - 10.1016/j.jiph.2021.04.006

Subject(s) - seroprevalence , medicine , pandemic , population , covid-19 , veterinary medicine , virology , disease , immunology , serology , environmental health , infectious disease (medical specialty) , antibody

Estimated seroprevalence of Coronavirus Infectious Disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is a critical evidence for a better evaluation of the virus spread and monitoring the progress of COVID-19 pandemic in a population. In the Kingdom of Saudi Arabia (KSA), SARS-CoV-2 seroprevalence has been reported in specific regions, but an extensive nationwide study has not been reported. Here, we report a nationwide study to determine the prevalence of SARS-CoV-2 in the population of KSA during the pandemic, using serum samples from healthy blood donors, non-COVID patients and healthcare workers (HCWs) in six different regions of the kingdom, with addition samples from COVID-19 patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research